We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+27.94%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.4B
AUM Growth
+$6.4B
(+19%)
Cap. Flow
-$900M
Cap. Flow
% of AUM
-2.23%
Top 10 Holdings %
Top 10 Hldgs %
16.03%
Holding
2,489
New
261
Increased
810
Reduced
1,082
Closed
259
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$245M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$143M |
| 3 |
3M
MMM
|
+$142M |
| 4 |
Public Service Enterprise Group
PEG
|
+$108M |
| 5 |
KeyCorp
KEY
|
+$80.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$378M |
| 2 |
Kimberly-Clark
KMB
|
+$186M |
| 3 |
Altria Group
MO
|
+$141M |
| 4 |
AbbVie
ABBV
|
+$141M |
| 5 |
Pfizer
PFE
|
+$120M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.35% |
| 2 | Technology | 19% |
| 3 | Consumer Discretionary | 10.55% |
| 4 | Financials | 9.89% |
| 5 | Communication Services | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Armstrong World Industries
AWI
$6.67B
| $11.6M | 0.03% |
149,384
+148,574
| +18,342% | +$11.3M |
|
502
OrthoPediatrics
KIDS
$604M
| $11.6M | 0.03% |
264,908
+99,983
| +61% | +$4.5M |
|
503
Brink's
BCO
$4.47B
| $11.5M | 0.03% |
253,610
+241,375
| +1,973% | +$11M |
|
504
Boston Beer
SAM
$1.75B
| $11.5M | 0.03% |
21,507
+19,183
| +825% | +$9.29M |
|
505
Revvity
RVTY
$16.3B
| $11.5M | 0.03% |
117,352
+116,278
| +10,827% | +$10.6M |
|
506
Halozyme
HALO
$12.3B
| $11.5M | 0.03% |
429,266
+369,599
| +619% | +$8.34M |
|
507
Cars.com
CARS
$617M
| $11.5M | 0.03% |
1,993,688
+758,029
| +61% | +$4.19M |
|
|
UFS
508
DELISTED
DOMTAR CORPORATION (New)
UFS
| $11.5M | 0.03% |
542,917
+4,037
| +0.7% | +$87.6K |
|
509
Church & Dwight Co
CHD
$22.7B
| $11.4M | 0.03% |
147,236
-148,391
| -50% | -$10.8M |
|
510
Arch Capital
ACGL
$33.1B
| $11.4M | 0.03% |
396,445
+188,088
| +90% | +$5.2M |
|
511
Brighthouse Financial
BHF
$2.81B
| $11.3M | 0.03% |
407,301
-5,325
| -1% | -$147K |
|
512
Exponent
EXPO
$3.23B
| $11.3M | 0.03% |
139,964
-275,336
| -66% | -$19.8M |
|
513
NMI Holdings
NMIH
$3.23B
| $11.3M | 0.03% |
703,821
+149,699
| +27% | +$2.13M |
|
|
ISBC
514
DELISTED
Investors Bancorp, Inc.
ISBC
| $11.3M | 0.03% |
1,327,960
+66,589
| +5% | +$560K |
|
515
Sanofi
SNY
$102B
| $11.3M | 0.03% |
220,752
-97,403
| -31% | -$4.73M |
|
516
Sun Communities
SUI
$14B
| $11.3M | 0.03% |
82,972
+10,191
| +14% | +$1.35M |
|
517
Hershey
HSY
$34.3B
| $11.3M | 0.03% |
86,803
+69,377
| +398% | +$9.33M |
|
518
Interparfums
IPAR
$3.61B
| $11.3M | 0.03% |
233,640
+135,907
| +139% | +$6.12M |
|
519
Emergent Biosolutions
EBS
$346M
| $11.2M | 0.03% |
141,616
-73,746
| -34% | -$5.5M |
|
520
Halliburton
HAL
$28.8B
| $11.2M | 0.03% |
859,408
-485,689
| -36% | -$5.24M |
|
521
Melco Resorts & Entertainment
MLCO
$1.73B
| $11.1M | 0.03% |
714,197
+129,414
| +22% | +$2M |
|
522
CVS Health
CVS
$117B
| $11M | 0.03% |
169,575
+75,047
| +79% | +$4.73M |
|
523
Atlassian
TEAM
$48.2B
| $11M | 0.03% |
60,869
-178,341
| -75% | -$29.6M |
|
|
MNTA
524
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $10.9M | 0.03% |
327,430
+100,042
| +44% | +$3.19M |
|
525
ICICI Bank
IBN
$101B
| $10.8M | 0.03% |
1,167,433
+345,312
| +42% | +$3.07M |
|
Similar funds
Federated Hermes's Q2 2020 Portfolio in Review
As of Q2 2020, Federated Hermes held 2,489 positions worth $40.4B, up 19% from $34B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2020 filing shows 261 new, 810 increased, 1,082 reduced and 259 closed positions. Its largest new stake was ZoomInfo Technologies: 1,084,200 shares worth $55.3M. The largest sale was Gilead Sciences, an estimated $378M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Discretionary.
- Federated Hermes's largest Q2 2020 buy was ZoomInfo Technologies: 1,084,200 shares worth $55.3M.
- Federated Hermes added most to IBM in Q2 2020, an estimated $245M increase.
- Federated Hermes's biggest Q2 2020 reduction was Gilead Sciences, cutting an estimated $378M.
- Federated Hermes fully exited Invesco in Q2 2020, selling an estimated $62.7M.
- Federated Hermes's ten largest holdings make up 16% of its $40.4B portfolio in Q2 2020.
- Federated Hermes opened 261 new positions and closed 259 in Q2 2020.
- Federated Hermes's portfolio value rose 19% quarter-over-quarter to $40.4B.
Based on Federated Hermes's 13F filing for Q2 2020, filed 13 Aug 2020.